A study with four oral anti-Hepatitis drugs in patients with Hepatitis C who have already had at least one round of treatment

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-002748-28

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• To evaluate the antiviral efficacy as measured by SVR of combination therapy with GS-5885, GS-9451, tegobuvir and RBV compared with GS-5885, GS-9451 and tegobuvir or GS-5885, GS-9451 and RBV in treatment-experienced subjects with chronic genotype 1a or 1b HCV infection • To evaluate the safety and tolerability of each regimen in treatment-experienced subjects with chronic genotype 1a or 1b HCV infection


Critère d'inclusion

  • Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Liens